Market Access World USA 2010 is the most important event that is proposed to convene a huge number of pharma market access thought leaders, providing them the complete review of US health reform. It will offer an overview of how government agencies are seeking to control drug costs and decrease budget deficits due to economic recession whilst widening enduring entrance. The novel strategies that will be focused in the event are: new drug pricing systems comprising risk sharing agreements; the utilization of independent health technology assessment agencies top offer direction on new treatments; the use of relative effectiveness studies to assess drugs. Market Access World USA 2010 will enable the attendees to learn all the key tools and techniques for pharmaceuticals market access.
The targeted visitors in the event Market Access World USA 2010 are:
- Pharmaceutical and Medical Device Manufacturers
- Senior VPs and Directors of R&D
- Chief Pharmacy Officers
- Chief Medical Officers
- Employee Health Benefit Professionals
- Government Health Officials